<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04305158</url>
  </required_header>
  <id_info>
    <org_study_id>239435</org_study_id>
    <nct_id>NCT04305158</nct_id>
  </id_info>
  <brief_title>Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA</brief_title>
  <official_title>Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colon cancer is the second most common cancer in men and the third most common cancer in&#xD;
      women worldwide. The clinical objectives of administering sedation for GI endoscopy are to&#xD;
      relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of&#xD;
      N2O could potentially provide an alternate safe and cheap option for patients who do not&#xD;
      prefer IV sedation for colonoscopy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients who are considered low risk for anesthesia administration (ASA class &lt;IV) receive&#xD;
      moderate sedation with a combination of intravenous benzodiazepine and opioid medication. an&#xD;
      alternative method of providing analgesia with &quot;on-demand&quot; inhalation of nitrous oxide&#xD;
      (hereafter referred to as N2O) combined with oxygen has been postulated. Nitrous Oxide has&#xD;
      been used for analgesia in various procedures including childbirth, general anesthesia,&#xD;
      pediatric dentistry, bone marrow aspiration, fracture reductions, and minor surgical&#xD;
      procedures (surgical dressings, pulmonary endoscopy, an abscess . It could potentially reduce&#xD;
      overall costs for the procedure, in addition to providing a quicker recovery, turn over&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cecal intubation rates and time of the procedure - total time and recovery</measure>
    <time_frame>1 to 30 minutes</time_frame>
    <description>Time required to complete the procedure and reach end of the colon</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Nitrous Oxide</condition>
  <arm_group>
    <arm_group_label>Nitrous Oxide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient receiving Nitrous Oxide are evaluated for success of the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV Sedation group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group a combination of Midazolam and Fentanyl is used per endoscopic discretion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitrous Oxide</intervention_name>
    <description>Patient receiving nitrous oxide are evaluated for success of the procedure</description>
    <arm_group_label>IV Sedation group</arm_group_label>
    <arm_group_label>Nitrous Oxide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Men and women, more than 18 years old Scheduled for a colonoscopy at the Endoscopy unit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  High ASA risk (IV/ &gt;)&#xD;
&#xD;
          -  History of chronic pain&#xD;
&#xD;
          -  Allergy to N2O or opioid or BDZ&#xD;
&#xD;
          -  Non-English-speaking patients&#xD;
&#xD;
          -  No consent&#xD;
&#xD;
          -  Recent head injury with impairment of consciousness or Intracranial / Middle Ear&#xD;
             surgery within the previous 6 months with or without residual deficits.&#xD;
&#xD;
          -  Pneumothorax, air embolism&#xD;
&#xD;
          -  Decompression sickness or within 48 hours of an underwater dive&#xD;
&#xD;
          -  Severe emphysema with bullae&#xD;
&#xD;
          -  Gross abdominal distension with suspicion for bowel obstruction&#xD;
&#xD;
          -  Intoxication&#xD;
&#xD;
          -  Maxillofacial injuries (where patient unable to administer the drug using a&#xD;
             mouthpiece/mask, or there is the risk of causing further damage to facial wounds and&#xD;
             there may also be a significant risk of blood inhalation)&#xD;
&#xD;
          -  Patients with chronic pulmonary disease for whom an inspired oxygen concentration of&#xD;
             more than 28% oxygen might be dangerous&#xD;
&#xD;
          -  Patients on Methotrexate&#xD;
&#xD;
          -  Where patients need assistance to hold the mask or mouthpiece.&#xD;
&#xD;
          -  Retinal surgery within the last three months&#xD;
&#xD;
          -  Any patient who does not otherwise clinically qualify for standard sedation methods&#xD;
             (i.e., those who require general anesthesia)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin Tharian, MD, MRCP, FACP, FRACP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin Tharian, MD, MRCP, FACP, FRACP</last_name>
    <phone>501-686-7847</phone>
    <email>BTharian@uams.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abhilash Perisetti</last_name>
    <phone>501-686-7847</phone>
    <email>APerisetti@uams.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Tharian, MD, MRCP, FACP, FRACP</last_name>
      <phone>501-686-7847</phone>
      <email>BTharian@uams.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>March 9, 2020</study_first_submitted>
  <study_first_submitted_qc>March 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2020</study_first_posted>
  <last_update_submitted>July 15, 2021</last_update_submitted>
  <last_update_submitted_qc>July 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Moderate sedation</keyword>
  <keyword>Nitrous oxide</keyword>
  <keyword>Screen colonoscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitrous Oxide</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

